GGrantIndex
Sort

141,003 grants matching cytokine

MOLECULAR MECHANISMS OF PROGRESSIVE RENAL DISORDERS

$782,831
University Of Kansas Medical Center · P01 · FY2001 · DK

Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract

$782,815
Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI

Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract

$782,815
Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES

$782,709
University Of Minnesota Twin Cities · R01 · FY2001 · DK

AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma

$782,691
Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2023 · CA

Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus

$782,684
Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI

Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus

$782,684
Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI

Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus

$782,684
Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI

Role of gamma/delta T cells in Vaccine Induced Immunity

$782,578
Daniel F. Hoft · Saint Louis University · R01 · FY2017 · AI

Fetal HCMV Infection: Role of the Human Placenta

$782,559
Lenore Palma Pereira · University Of California, San Francisco · R01 · FY2016 · AI

Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure

$782,500
Kory J. Lavine · Washington University · R35 · FY2023 · HL

Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA

$782,480
Vladimir P Torchilin · Northeastern University · U54 · FY2011 · CA

Lymphoma Studies

$782,468
Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

Respiratory Drive in Acute Respiratory Failure

$782,461
Jeremy R. Beitler · Columbia University Health Sciences · R01 · FY2024 · HL

Drug-eluting fibers for on-demand and extended protection against HIV

$782,421
Kim A. Woodrow · University Of Washington · R01 · FY2021 · AI

The Role Of Innate Immunity Genes In Viral Infection and Disease Progression

$782,391
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

Immunology Core

$782,378
Paul A Volberding · University Of California, San Francisco · P30 · FY2014 · AI

The Role of TREK-1 potassium channels in ARDS

$782,362
Andreas Schwingshackl · University Of California Los Angeles · R01 · FY2024 · HL

The Role of TREK-1 potassium channels in ARDS

$782,362
Andreas Schwingshackl · University Of California Los Angeles · R01 · FY2025 · HL

Longtitudinal Studies of HIV-Associated Bacterial Pneumonia

$782,285
William N Rom · New York University School Of Medicine · R01 · FY2007 · HL

Immunophysiological Mechanisms in the Biological Therapy of Cancer

$782,272
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Integrative multi-omics for discovery of molecular pathways associated with diabetic retinopathy

$782,235
Dolly Ann Padovani-Claudio · Vanderbilt University Medical Center · R01 · FY2024 · EY

Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention

$782,126
Abdullah Kutlar · Augusta University · R33 · FY2023 · HL

Leadership, Planning, and Evaluation

$782,071
Gary K Schwartz · Case Western Reserve University · P30 · FY2023 · CA

Leadership, Planning, and Evaluation

$782,071
Gary K Schwartz · Case Western Reserve University · P30 · FY2024 · CA